BeStock  
Stocks › Biotechnology › OCUL

Ocular Therapeutix OCUL

US equityMarket cap rank #2935Biotechnology
$7.25 +$0.29 (+4.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.25 -0.02%
Open$6.93
Prev close$6.96
Day range$6.79 – $7.27
Volume5.62M
Market cap$1.59B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$25.57+252.7% vs. price
  • Buy 100%
Low $18.00Now $7.25Avg $25.57High $31.00

Recent rating changes

The last 20 actions on file set price targets from $18.00 to $31.00, averaging $25.63.

DateFirmRatingTarget
29 Sep 2026 Piper Sandler BUY $31.00
28 Sep 2026 Needham BUY $18.00
25 Sep 2026 William Blair BUY –
16 Sep 2026 H.C. Wainwright BUY $25.00
15 Sep 2026 William Blair BUY –
15 Sep 2026 BofA Securities BUY $27.00
26 Aug 2026 Piper Sandler BUY $31.00
20 Aug 2026 BofA Securities BUY $27.00
18 Aug 2026 Clear Street BUY $28.00
17 Aug 2026 William Blair BUY –
17 Aug 2026 Needham BUY $18.00
7 Aug 2026 BofA Securities BUY $27.00
4 Aug 2026 Clear Street BUY $28.00
4 Aug 2026 H.C. Wainwright BUY $25.00
3 Aug 2026 TD Cowen BUY $20.00
3 Aug 2026 William Blair BUY –
3 Aug 2026 Needham BUY $18.00
3 Aug 2026 RBC Capital BUY $30.00
30 Jul 2026 RBC Capital BUY $30.00
22 Jun 2026 BofA Securities BUY $27.00

Discussion

No comments yet — be the first to weigh in on OCUL.

Leave a comment

Scroll to Top